4
Changes in Ownership
Dermata Therapeutics, Inc. Filed Acc 0001493152-25-029470
SVP, CFO acquired 122,549 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Van Hoose Kyri K. SVP, CFO | 2025-12-23 | Grant or award | +122,549 | 130,423 | D | ||
| Derivatives | |||||||
| Van Hoose Kyri K. SVP, CFO | 2025-12-23 | Grant or award · Series C Warrant (Right to Buy) | +122,549 | 122,549 | D | ||
| Van Hoose Kyri K. SVP, CFO | 2025-12-23 | Grant or award · Series D Warrant (Right to Buy) | +122,549 | 122,549 | D | ||
| Van Hoose Kyri K. SVP, CFO | 2025-12-23 | Returned to the company · Warrant (Right to Buy) | +7,874 | 0 | D | ||
| Van Hoose Kyri K. SVP, CFO | 2025-12-23 | Grant or award · Warrant (Right to Buy) | +7,874 | 7,874 | D | ||
Loading xslF345X05/ownership.xml…